MiR-150 has been reported to be overexpressed in CLL [173] and underexpressed in chronic myelogenous leukaemia (CML), where its decreased levels are suggested to potentiate MYB and BCR-ABL expression [187]. The gene discussed is MYB; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.